MedPath

Kinarus AG

Kinarus AG logo
πŸ‡¨πŸ‡­Switzerland
Ownership
Public, Subsidiary
Established
2017-09-01
Employees
1
Market Cap
-
Website
http://www.kinarus.com

The KIN-FAST Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2

Phase 2
Terminated
Conditions
COVID-19
Interventions
Drug: KIN001-Placebo
First Posted Date
2022-12-21
Last Posted Date
2025-03-14
Lead Sponsor
Kinarus AG
Target Recruit Count
17
Registration Number
NCT05659459
Locations
πŸ‡¨πŸ‡­

Cabinet Dr. Thanh, Nyon, Switzerland

πŸ‡©πŸ‡ͺ

Praxis am Ebertsplatz, Cologne, Germany

πŸ‡©πŸ‡ͺ

Velocity Clinical Research Hamburg, Hamburg, Germany

and more 5 locations
Β© Copyright 2025. All Rights Reserved by MedPath